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Abstract
Xenografting is widely used for assessing in vivo pluripotency of human stem cell populations. Here, we report on early to
late events in the development of mature experimental teratoma from a well-characterized human embryonic stem cell
(HESC) line, HS181. The results show an embryonic process, increasingly chaotic. Active proliferation of the stem cell derived
cellular progeny was detected already at day 5, and characterized by the appearance of multiple sites of engraftment, with
structures of single or pseudostratified columnar epithelium surrounding small cavities. The striking histological
resemblance to developing embryonic ectoderm, and the formation of epiblast-like structures was supported by the
expression of the markers OCT4, NANOG, SSEA-4 and KLF4, but a lack of REX1. The early neural marker NESTIN was
uniformly expressed, while markers linked to gastrulation, such as BMP-4, NODAL or BRACHYURY were not detected. Thus,
observations on day 5 indicated differentiation comparable to the most early transient cell populations in human post
implantation development. Confirming and expanding on previous findings from HS181 xenografts, these early events were
followed by an increasingly chaotic development, incorporated in the formation of a benign teratoma with complex
embryonic components. In the mature HS181 teratomas not all types of organs/tissues were detected, indicating a
restricted differentiation, and a lack of adequate spatial developmental cues during the further teratoma formation.
Uniquely, a kinetic alignment of rare complex structures was made to human embryos at diagnosed gestation stages,
showing minor kinetic deviations between HS181 teratoma and the human counterpart.
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Introduction
Studies in vitro have revealed that human embryonic stem cells
(HESC) can recapitulate key developmental differentiation events
and exhibit a remarkable capacity to differentiate into diverse
specialized cell types in vitro [1]. Furthermore, HESC are known to
spontaneously differentiate into derivatives of all germ layers when
xenografted in vivo [2]. The developing growths from xenografted
HESC with normal karyotype show histologic analogies with
clinical benign mature teratoma and represent chaotic embryonic
tissues and initial organoid development [3–5]. Consequently, the
‘‘teratoma assay’’ has become a standard for evaluating in vivo
pluripotency of human cell lines [6–8].
Although by many referred to as tumors, experimental
teratomas induced by pluripotent stem cells can alternatively be
regarded as a manifestation of a failed progress of embryonic
development resulting from the ectopic implantation [9]. It has
been hypothesized, as reviewed e.g. by Blum and Benvenisto [3],
that in vivo differentiation of HESC would resemble normal
embryonic processes, albeit in a disorganized manner. Using
systematic histological examinations and a large set of antibodies,
we have earlier described in detail the various tissues within
mature teratoma originating from xenografts of the HESC line
HS181 [10]. These observations, extending on previously
published literature on in vivo development of HESC, illustrated
HS181 differentiation into discernible and probably functional
tissues and also underscored the relative participation of mouse
and human cells.
We are not aware of any published study on in vivo kinetics or
distribution of tissues from the three germ layers in HESC
teratoma. Here, we describe a first attempt, again using the well-
characterized HS181 cell line, to study also the early stages of
HESC mouse xenografts. Interestingly, the resulting growth
showed pronounced similarities to embryonic ectoderm/epiblast
PLoS ONE | www.plosone.org 1 November 2011 | Volume 6 | Issue 11 | e27741formation, compatible, and in time aligned, with the most early
transient cell populations in human post implantation develop-
ment.
Results
Events days 5–10
Three out of five samples (half teratoma; see material and
methods) were day 5 positive for human cells and found to
include visible sites of HS181 engraftment. In the positive
samples, multiple sites of engraftment were found located
interstitially between the mouse seminiferous tubules, and
consisted of structures characterized by a tubular pattern lined
with a single or pseudostratified columnar epithelium (FIG 1A–
D). The human origin of these cells was positively verified by
FISH analysis using a human specific probe (FIG 1B). Mitotic
and apoptotic figures were detected, indicating active prolifera-
tion and some cell death.
Also at day 5, human cells with a non-epithelial morphology,
possibly representing primary endoderm, were observed adjacent
to and surrounding the epithelia formation (FIG 1A–D). In the
proximity of the engraftment, in the testis tissues, an increased
frequency of mouse vascular structures were detected by day 5
(FIG 1D) and onwards.
The presence of embryonic epithelium was further supported by
marker analysis. The day 5 epithelial tissue was found positive for
markers such as OCT4, NANOG and SSEA-4 (FIG 2A,B,E), but
negative for markers FGF5 and REX1 (FIG 2C,D). Notably, the
early neural marker NESTIN, was found in all epithelia at this
stage (FIG 2F). Also, the human KLF4 gene was expressed
(Fig 2G). Transcription of BMP-4, NODAL BRACHYURY or
MIXL-1 was not detected using RT-PCR on day 5 samples (data
not shown).
Four out of five testes samples at day 10 included signs of
engraftment. At this stage a gradual increase of the epithelial
multilayered structures was apparent.
Figure 1. Histology at day 5. (A) HE stained section of mouse testis at day 5 following the injection of HS181 cells. Surrounded by mouse
seminiferous tubules (=ST) a site of initiated growth dominated by multiple appearance of epithelia; in the center of the picture (10x orig.
magnification). (B) Illustrates how the human origin of such implanted structures can verified using FISH analysis with human specific probe (40x orig
magnification). (C) Illustrates bulging single-and multilayered epithelia, and in (D) higher magnification of the boxed area in C, showing ample mitosis
and frequent apoptotic bodies (arrows). Red arrows indicate mouse blood vessels adjacent to implantation (C=20x and D=40x orginal
magnification).
doi:10.1371/journal.pone.0027741.g001
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Three out of five samples were positive for human cells at day
20 and the same frequency was found for the samples of day 30.
Contrary to earlier time points, the occurrence of apoptotic
figures was low in the teratoma growth at day 30 (exemplified in
FIG 3A,B). Notably, a gradual destruction of the host testicular
parenchyma occurred, with the first signs of degeneration of
seminiferous tubules day 5, to reaching a near complete
destruction of the host tissues at day 30 (not shown).
At day 30, diversified teratoma tissues started to occur,
dominated by expanding multilayered epithelium (FIG 3A,B, and
4). The pluripotency marker SSEA4 was still detected in single
layered epithelia day 30, while multilayered structures at this time
point tended to be negative for this marker (FIG 3D). Figure 4A–I
depicts serial sections from a day 30 teratoma stained with an array
of differentiation markers, illustrating a non homogenous intra-
teratoma distribution of proliferative areas (Ki67) largely overlap-
pingwith areasstainedwithCD56(hereamarkerforectoderm)and
excluding areas stained with AFP (early marker for endoderm).
High rates of proliferation, indicated by Ki67 staining, could be
observed mainly in areas compatible with neuroepithelium
(FIG 3C and overview in FIG 4A). From day 20 to day 30 the
testis outer diameter was nearly doubled as judged by palpation
(data not shown). In line with previous reports on HS181 and also
other HESC lines [10,11], the vascularization was mainly of host
origin, with only sparse presence of immature human vessels,
indicated by CD31/34 staining (FIG 4C,D).
Also, from this time point and after, cystic components
containing gelatinous liquid were frequently detected in the
majority of teratomas (FIG 4).
Figure 2. Marker studies day 5. (A) IHC for OCT-4; positive staining of epithelial and non-epithelial structures. (B) IHC for NANOG; positive staining
of epithelial and non-epithelial structures. (C) IHC for FGF5; negative. (D) IHC for REX-1; negative. (E) IHC showing positive staining for SSEA-4 in low
numbers of cells in epithelia. (F) IHC showing homogenous expression of NESTIN in all epithelia. IHC was in all cases counterstained with DAPI (blue).
A–F=20x original magnification. (G) RT-PCR analysis. Lanes; M=100 bp ladder. 1=HS181p38 (positive control). 2–6=Testis from 5 animals following
injections with HS181p38 cells 5 days earlier. 7=Reaction mix without template (negative control). GAPDH PCR expected product length=475 bp.
KLF4 PCR expected product length=182 bp.
doi:10.1371/journal.pone.0027741.g002
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nor structures suggesting early heart formation, were found in any
of the preparations throughout the study. An in vitro potential of
HS181 for cardiac development of HS181 cells has however been
previously shown by development of beaters [12,13].
In one exceptional case at day 30, the teratoma showed a
separate structure with features characteristic for early limb
formation (FIG 5). In this case, a centrally condensing mesenchyme
was covered by a thin, two-layered epithelium, with the peripheral
layer consisting of thin elongated cells (FIG 5A). The epithelial cell
layers were outlined with E-CADHERIN (FIG 5B), compatible
with the situation in early differentiation of the mammalian
epidermis. Fully consistent with early epidermal development,
IHC revealed intense expression of nuclear P63 (FIG 5C).
Peripheral cells were flat and positive for CK18 (FIG 5D).
Expression of the neural cell adhesion molecule (N-CAM/CD56),
a marker oflimb morphogenesis and a findingcharacteristic of early
pre-cartilaginous development, confirmed central mesenchymal
condensation (FIG 5E) [14]. Scattered cells localized basally in the
epidermis were proliferative, and an intense proliferative activity
was also seen throughout the mesenchyme (FIG 5F).
Events day 60
At day 60, four out of the five testes showed palpable teratoma
growth. All teratomas were at day 60 still well encapsulated and
expanding rather than infiltrating the testicular capsule. No evidence
for the appearance of malignant phenotypes was detected.As expected,
a rich variety of tissues, with a chaotic distribution, were observed.
Staining for Ki67 indicated that proliferating multilayered
neuroepithelium was still found day 60 and composed of both
proliferative compartments, as well as post-mitotic neuronal precur-
sors (Fig 6A). Neurogenesis, with presence of ganglionic areas and
nerve fibers, was supported by staining with NFP (Fig 6B,C), bIII-
tubulin (Fig 6E) and doublecortin (Fig 6D,F). Thus, in this respect
markers of the neural maturation from HESC appeared day 60 to
match an early stage of cortical plate development.
Figure 3. Histology and marker studies day 30. (A) HE staining of teratoma section day 30 showing diverse teratoma tissues. (B) Higher
magnification of detail in A (dashed box), demonstrating expanding multilayer epithelium with low frequency or lack of apoptotic bodies. (C) IHC;
intense Ki 67 staining in area of epithelial cells indicating high proliferation rates. (D) IHC showing SSEA4 positive cells at multiple sites of single layer
epithelium (examplifed by the grey arrows) and a low frequency of SSEA4 cells in multilayered epithelium (white arrow). A=10x, B=40x and
C,D=20x original magnification.
doi:10.1371/journal.pone.0027741.g003
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development,day60showedagradientofcartilagematuringtoward
stages of early endochondral bone formation. Advanced structures
compatible with renal development were rare findings at day 60.
These structures were found in association with a condensing
mesenchyme of nephrogenic character, positive for WT1 staining
and with partially vascularized primitive glomeruli and tubuli (data
not shown), in line with previous reports [2,10,15–18].
Figure 7 shows a summary of recognized advanced tissues in
HS181 teratoma, time aligned with human development.
Teratoma development with striking similarities to human fetal
development were revealed (FIG 7J,K,L).
Discussion
Studies of mice have provided detailed important information
on mammal post implantation development (see e.g. The e-Mouse
Atlas Project (EMAP): www.emouseatlas.org/emap/). From this, a
striking morphological overlap can be appreciated between the
mouse Theiler Stages (TS) 7 and 8 and the here observed
structures in day 5 HS181 xenografts (Fig 1–2). Parallels between
mouse and human developmental stages have been described [19],
and suggest that TS8 best matches the human Carnegie stage (CS)
5, equivalent to gestation days 7–13. While considerably less is
known about the earliest stages of human post implantation, the
HS181 development at day 5 showed resemblance to human post
implantation development as it is recognized at human CS5a–c
[20]. In analogy, a resemblance could also be perceived with
preimplantation stages of baboon as beautifully illustrated by
Tarara, et al. [21].
Teratomas induced by pluripotent stem cells have generally
been referred to as benign tumor formation [3]. Our results
studying the pluripotent HESC line HS181 supports the notion of
a failed, increasingly chaotic, embryonic process. Notably, the
early HS181 xenografts exhibited multiple sites of growth
initiation, in this aspect supporting the suggestion from Blum
and Benvenisto that in vivo differentiation of HESC is polyclonal
[22]. Furthermore, the early structures showed both pseudostrat-
ified and multilayered epithelium, suggesting presence of asyn-
chronous developmental stages.
Figure 4. Sections from HS181 day 30 teratoma. (A) IHC; Ki67 staining (mitotic marker). (B) IHC; CD56/NCAM (Neural cell adhesion molecule). (C)
IHC: sparse staining of CD34 and (D) IHC; CD31/PECAM (Platelet endothelial cell adhesion molecule). (E) E-CAD (epithelial cadherin). (F) IHC: P63 (epithelial
cells). (G) IHC; CK18 (Cytokeratin 18). (H) IHC; Negative staining for NFP (Neurofilament protein). (I) IHC; AFP (alfafetoprotein). A–I=10x original magnification.
doi:10.1371/journal.pone.0027741.g004
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blastocyst on day 6 after fertilization [12], with an embryo grading
score of 4BB [23], i.e. an expanded blastocyst with small cell
numbersintheinnercellmassandtrophectoderm.Inthiscontext,it
was intriguing that HS181 early xenografts could reorganize into
epithelial structures with a marker profile largely resembling
developing embryonic ectoderm. Several findings supported the
presence of developing neural ectoderm. Nestin is expressed in the
majority of mitotically active neural progenitors and commonly
interpreted as a marker for neuronal stem cells [24]. The finding of
NESTIN expression in all initial epithelia day 5 thus indicated the
presence of primitive neural ectoderm. SSEA-4 [25], a marker
linked to stemness, could be detected in single cell epithelia in the
teratomas up to day 30. NODAL signaling is essential for the
maintenance of HESC pluripotency [26,27] and is present in
undifferentiated HS181 cells [7] (and data not shown). Using
sensitive RT-PCR we did not detect expression of NODAL in day 5
teratomas.Nodalisreportedessentialforprimitivestreakformation,
as well as for early mesoderm and endoderm development in mouse
[28,29].However, inhibition ofNodal-/Activin-signalingisessential
forinductionofneuroectoderm invitroandduringgastrulation in vivo
[30,31]. Thus, the absence of NODAL at day 5 is in line with a
presence of primitive neural ectoderm.
NANOG is reported to repress differentiation into primitive
endoderm [32] and was found to be expressed day 5. Fibroblast
growth factor 5 (FGF5) is a major marker for pluripotent primitive
ectoderm just prior to gastrulation [33,34]. It is also expressed in
the undifferentiated HS181 cells ([7], and data not shown).
Surprisingly, the day 5 ectoderm-like cells were negative for FGF5
using IHC. Vallier, et al. [26] reported that human equivalents of
early primitive ectoderm-like cells (EPL cells, as described by
Rathjen, et al. [35]) did not express FGF5. Although different
experimental systems were used, the data from Vallier, et al. are of
interest in the context of our negative findings for FGF5.
The NESTIN-positive epithelial day 5 structures were BMP4
negative (as shown by RT-PCR in 3/3 samples), a condition likely
to have influenced the early neuronal dominance. The first 30
days were almost completely dominated by neuroepithelium.
Besides the early devoid of BMP-4, other markers for
gastrulation, e.g. BRACHYURY, SHH, and WNT’s were also
initially absent. In the mature teratomas, only limited presence of
derivatives from the paraxial or lateral mesoderm was observed
and a smaller portion of other ectodermal derivatives was
identified. In this perspective, it is possible that the extensive
cartilage observed could in fact have been derived from the
forming of neural crest or prechordal plate mesoderm.
When subjected to neural in vitro differentiation protocols, or
spontaneously just following suboptimal culture conditions,
HS181, like other HESC lines, forms radial arrangements of
elongated columnar cells (‘‘neural rosettes’’), surrounded by flat
epithelial cells. In our experience, for HS181, this occurs
approximately day 9 following the removal of conditions
supporting undifferentiated growth (unpublished). In vivo neural
rosette formation in the HS181-xenografts could first be observed
from day 10, thus in this respect closely following the in vitro
findings.
Collectively, the above discussed results suggest that early
HESC xenografts may provide a hitherto overlooked route for
studies of the most early transient cell populations in development.
For ethical reasons, there is no apparent natural ectopic site for
reinstating HESC to in vivo development. Site-dependent tissue
composition of HESC-teratoma was not detected in studies by
Figure 5. Day 30 development compatible with early limb bud formation. (A) HE staining showing structure resembling limb bud
morphology, containing micro vessels. (B) IHC; E-cadherin is found in the ectodermal rim of which the second layer is p63 positive (C), while the most
apical cells are CK18 positive (E). Mesenchymal condensation was indicated by CD56 staining (D) and the internal mesenchymal core showed to be
highly proliferative by Ki67 staining (F), while the ectodermal surface contained more post proliferative cells. A=10x and B,C,D,E,F=40x original
magnification.
doi:10.1371/journal.pone.0027741.g005
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aggressive character following injections into liver [37]. In our
studies, the site of injection was chosen for reasons described
earlier [10]; i.e. the testis is not a vital organ, it is relatively easy to
access and the growth can at least be partially monitored by
external examination. However, the hypoxic status in mouse testis
[38,39] together with an explicit germ cell-promoting environ-
ment, as well as species related interference [40], may well have
interfered with the engraftment. A gradual destruction of the
mouse testicular parenchyma was evident in that some degener-
ation of seminiferous tubules occurred as early as day 5. This was
followed by a nearly complete destruction of the host tissues,
leaving only dispersed remaining host cells embedded within
human tissues by day 30. Thus, while the relative influence from a
human microenvironment increased with the build up of tissues,
the influence from the host testis gradually decreased and was in
the mature teratoma limited to mainly blood support. We did not
at any stage of teratoma formation observe cellular immune
infiltration. Immune interactions with the host was minimized,
since the host SCID/Beige mice lack both T and B lymphocytes
due to a defect in V(D)J recombination, as well as macrophage
defects and selectively impaired NK cell functions [41,42].
Extending on the results of previous studies, areas of more
advanced embryonic structures were observed. A unique approach
used in this study was the opportunity for direct morphological
comparisons to sections from human embryos at diagnosed
gestation stages. This included three particularly notable observa-
tions. i) In human development, upper extremities appear as early
visible structures from CS12 (gestation day 28), followed by the
lower extremities emerging at CS14 (gestation days 33–35). Day
30 following HS181 teratoma initiation, a single case of limb bud
formation (upper or lower) was observed (Figure 6G). As illustrated
in Figures 6 the total time period of in vitro/vivo differentiation (36
days; i.e. 6 days of in vitro culture, plus 30 days in vivo as xenograft)
preceding the observed occurrence of the teratoma bud-like
structure is thus in agreement with the kinetics of human limb bud
development. ii) Similarly, at day 53, we observed a single case of a
trachea-like embryonic structure with suggestive respiratory
epithelium and surrounding muscularis externa (Figures 6I). iii)
The most advanced structure was observed at day 53 and
comprised of a single neural tube like structure diligently
harmonizing with the histology of a ventricular zone with central
channel (Figures 6J). Both these latter embryonic structures could
be time matched with reference material from a human embryo at
Figure 6. Neural differentiation in mature HS181 teratoma. Day 60 teratoma section with IHC staining for Ki67 (A) indicating proliferative
areas of multilayered neuroepithelium, and in a nearby section is stained for NFP (B), this way illustrating the segregation of proliferative and post
mitotic zones. Structure compatible with a gangliotic area with nerve fibers, stained for NFP (C) and for doublecortin (DCX) (D). A neuralepithelial
structure showing areas of positive staining for bIII-tubulin (TU20) (E) and for doublecortin (F). A–F=20x original magnification.
doi:10.1371/journal.pone.0027741.g006
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(illustrated in Figures 7K and 7L, respectively), indicating less
than one week discrepancy of the total time of in vitro/vivo
differentiation preceding the occurrence of these teratoma
structures, compared to human embryonic development.
In our present and previous studies using HS181, we have in
mature teratomas (.45 days) observed derivatives of intermediate
mesoderm including epithelium of endodermal origin resembling
early gut- and respiratory epithelial formation, as well as primitive
renal structures [10,15].
Advanced structures were rare and always occurring within a
progressively disorganized context and with apparently random
surroundings. Although several major developmental mile-
stones resembling gastrulation, neurulation etc could be
o b s e r v e d ,o t h e r sw e r em i s s i n g ,e . g .f o r m a t i o no fs o m i t e s
(expected at CS9) and heart (CS12). The absence of detectable
somitogenesis could possibly have contributed to the chaotic
progression [43–45].
Together, these in vivo results demonstrate the truly pluripotent
nature of the HS181 cell line (with all three germ layers
represented in xenografts), as well as a parallel restricted in vivo
development. This restriction could possibly partly be caused by
an imbalance between inductive and suppressive signals for
gastrulation and/or the distribution of the germ layers. Based on
studies on other HESC lines and literature reports, we tentatively
suggest that the observed strong bias for neuronal development
was likely due to restrictions endogenous for the cultured HS181
cells, and that inter-line variations can be expected [7,46].
Alternatively, the xenograft model per se may be the cause of the
restricting development. Detailed studies with a sizeable set of
different HESC lines are needed to solve this question, as well as to
learn about the possible generality of some of our findings using
the HS181 line. However, this initial stand-alone study on the
HESC line HS181 provides, for the first time, a detailed histology
of early teratoma development in parallel to marker analysis on
progression of typical events in benign HESC teratoma formation,
as well as evidence for an at least in time partly aligned embryonic
development.
Materials and Methods
Ethical permissions
This study was performed in strict accordance with permission
for experiments using human embryonic stem cells, from the Local
Ethics Committee at Karolinska Institute (114/00), and for animal
experimentation from the regional ethical committee (Stockholms
norra djurfo ¨rso ¨ksetiska na ¨mnd; Dnr S172-03 and N105/07).
Cell culture
The HESC line HS181, 46XX, p30/31 [12] was cultured as
previously described [47]. The cells used for this study were all from
the very same batch and concurrently injected, thus reducing
differences due to varying quality of the cells. (NB. Figure 7H
illustrates a teratoma resulted from a separate injection of HS181 p20).
Mice
Male C.B.-17/GbmsTac-scid-bgDF N7 mice, age 6 weeks, were
obtained from M&B, (Denmark) and kept under isolator
conditions in M2 cages on aspen wood chips (Beekay bedding,
Scanbur B&K AB, Sweden) with free access to water and rodent
diet (RM3(P) irr, Special Diet Services, UK), using artificial light
from 6.a.m. to 6 p.m, and room temperature between 24+/22uC,
and humidity of 55%+/210%.
Groups of 5 animals were used. Testes from non-injected
animals were used as controls.
Injection of HESC, development and analysis of teratoma
formation
Implantations were performed as described previously [10].
HS181 cells (passage 30–50, 3–4 days after splitting, i.e. in
logarithmic growth phase) were harvested mechanically immedi-
ately prior to implantation, and approximately 10
4 cells were
inoculated beneath the testicular capsule after the animals were
anesthetized using Isoflurane (Baxter, UK). Following this single
HS181 injection, at indicated time points, the testis was cut in two
halves using a razor blade, for either histology or RNA analysis.
Engraftment, i.e. presence of HS181 derived cells (teratoma
formation), was for each sample (at time points days 5, 10 and 20)
assayed by human-specific RT-PCR for GAPDH (data not
shown), or by Hematoxylin and Eosin (HE) staining and histology
(at time points days 30 and 60). Engraftment was also verified by
fluorescent in situ hybridization (FISH), using a human-specific
probe (FIG 1C).
In line with previous reports [10], the used number of HS181
cells resulted day 60 in palpable teratomas in 4/5 mice (80%).
Evidence for HS181 engraftment was correspondingly observed in
17/40 (42%) of the analyzed ‘‘half teratoma’’ samples.
For the histology/IHC analysis, sectioning with 5 mm sections
was used and for practical reasons we limited the analysis to
100 HE stained sections per testis sample. A summary of the
observations on engraftment and IHC for each sample analyzed
(half teratoma) is presented in Table S1.
Human specific fluorescent In Situ Hybridization (FISH)
A human specific FISH probe (Spectrum Red labeled total
human genomic DNA, Vysis Inc., Downers Grove, IL) was used to
verify the human origin of the formed tissues, as previously
described [10].
Immunohistochemistry (IHC)
IHC was used to identify the structures and characterize
differences in maturation in the sections obtained from HESC
Figure 7. Time alignment with human development. Summary of development in HS181 teratoma (left side), compared to available
information on human early development (right side). (A) Illustrates a mouse testes injected with HS181 cells (=teratoma assay day 0). In (B) multiple
initial human structures at day 5 of teratoma assay are indicated (dotted circle). (C) Shows a higher magnification of the epiblast-like epithelial
structures (see also Figure 1C). The structures show a striking morphological overlap with mouse Theiler Stages 7/8, best matching the human
Carnegie stage (CS) 5 (human gestation days 7–13). Notably, the HS181 cell line originated from a blastocyst on day 6 after fertilization, hence the day
5 of teratoma assay potentially align to day 11 of differentiation post fertilisation. Figures (D) and (E) show the gradual increase of the epithelial
multilayered structures at days 10 and 20 (see also Figure 3). (F) Shows an overview of day 30 mature teratoma and (G) a larger magnification of a
limb bud like structure (see text and Figure 3). (H) Shows an overview of a HS181/p20 mature teratoma at day 53 and (I) a teratoma structure largely
resembling (L) suggesting a ventricular zone with central channel (indicated with an arrow). Figures J–L illustrates available time matched information
from human development, (J) Depicts an implantation site at human CS5, and (K) a human embryo at CS14 (arrows indicate upper and lower limb
buds). (L) Shows a human embryo at CS21–22, illustrating a ventricular zone with central channel. (Reference picture from the Pathology unit
Danderyd Hospital, Sweden.) Illustrations of CS5 and CS14 (J,K) were kindly provided by Dr M. Hill, UNSW.
doi:10.1371/journal.pone.0027741.g007
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used is summarized in Table S2. Sections were deparaffinized in
xylene and rehydrated through graded series of ethanol.
Highlighted markers (*) in Table S2 were performed on TechMate
TM 500 Plus equipment, using the ChemMate Detection Kit and
Peroxidase/DAB (all from DAKO Cytomation, Glostrup, Den-
mark), and counterstained with hematoxylin.
Sections analyzed with antibodies against NESTIN, bIII-
Tubulin, doublecortin and SSEA-4 were blocked with 3% BSA
(fraction V, Sigma-Aldrich, St. Louis, MO) and 0.1% BSA-c
(Aurion, 900.022) for 40 min at room temperature. After blocking,
the sections were incubated with primary antibodies for 1 hour at
room temperature. Following the incubation with the primary
antibody, the slides were washed with PBS and incubated with a
secondary antibody, AlexaFluor488 (Molecular Probes Inc.
Eugene, OR), for 40 min at room temperature. After washing
with PBS, the sections were mounted with Vectashield containing
DAPI (Vector Laboratories Inc., Burlingame, CA). Stainings for
Oct4, Nanog, Rex1, FGF5 and Brachyury were performed using
Vectastain ABC Kit (Vector Laboratories Inc. Burlingame, CA) or
Goat HRP-Polymer Kit (Biocare Medical, Concord, CA),
depending on origin of the primary antibody (see Table S2).
The procedure recommended by the manufacturer was followed.
Control experiments were performed using unspecific isotypic
antibodies.
Reverse transcriptase - polymerase chain reaction (RT-
PCR)
Total RNA was extracted from the tissues using TRIzol reagent
following the manufacturer’s protocol (Invitrogen, Carlsbad, CA).
Thereafter, the RNA was DNase-treated (Invitrogen, Carlsbad,
CA) to avoid DNA contamination, precipitated and resolved in
DEPC treated water to obtain final concentration of 0.1 mg/ml.
Complementary DNA was synthesized using Superscript III First
Strand Synthesis System (Invitrogen, Carlsbad, CA) according to
the recommended protocol. Platinum Taq-polymerase was used in
the following PCR reaction containing cDNA synthesized from
20 ng total RNA. The qualities of the individual RNA
preparations were corroborated by a positive amplification of b-
actin or GAPDH. Markers studied and primer sequences used are
indicated in Table S3.
Supporting Information
Table S1 Summary of observations on engraftment and results
on IHC for each sample (half teratoma*) analysed. * Following
injections of HS181 cells, at indicated time points, the testis was
cut in two halves using a razor blade and one half used for
histology/IHC. ** Engraftment, i.e. presence of HS181 derived
cells (teratoma formation), was for each sample assayed by human-
specific RT-PCR for GAPDH, or human specific fluorescent in
situ hybridization (FISH), or by HE staining and histology
(palpable teratomas). Samples found positive for teratoma are
indicated by grey shade in the table.
(DOC)
Table S2 Immunohistochemistry: Primary antibodies
used. * Staining made on a TechMate TM 500Plus; {, {{
Staining was performed manually as described in the material and
methods section.
(DOC)
Table S3 RT-PCR; primer sequences and conditions.
(DOC)
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